skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

read more

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/21: Research Grant Cycle
Learn more

04/01/22: Fellow Exam Application Deadline
Learn more

06/01/22: Research Grant Cycle
Learn more

06/26/22: Membership Application Deadline to be eligible for AAOA Member rate for the 2022 Basic Course

08/01/22: Scientific Abstract Submission Deadline

09/01/22: Membership Application Deadline to be voted in at the 2022 Annual Meeting

EDUCATION

The education committee of the AAOA has put together an all-star lineup for this year’s virtual Annual Meeting taking place October 16th to 21st. Like last year, our Annual Meeting will offer live-stream and on-demand content. Some content will be available for self-paced on-demand viewing on September 15th, 2021. Learn More

IFAR

Available Now

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2021 AAOA Annual Meeting
Pre-launch Mid-September
Live Stream Starting on Oct 16 | Virtual
Learn More and Register

2022 AAOA Advanced Course
In-Person!!! Santa Fe, NM
January 13-15, 2022
Learn More and Register

2022 AAOA Basic Course
The Diptomat Beach Resort, Hollywood, FL
June 30-July 2, 2022

USP 797 Online Module
Learn More and Register

News and Updates

United Agrees To Give Physicians ERISA Rights in Connection with Repayment Demands

Bottom line Recent class action settlement gives all out-of-network (“ONET”) physicians important – and often overlooked –…

read more

Starting an Allergy Practice

The essential tools and pearls for a successful allergy practice by those who have done…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Interim Package and Resuming Non-COVID Care

Sharing the latest on the interim package and the news from CMS about resuming non-COVID care.

HILL UPDATES

  • Interim Package:
    • Despite signs of progress, an agreement on this package was not reached today. The Senate scheduled a pro forma session for Tuesday afternoon to try to pass the interim package assuming a deal is reached and the House could vote as soon as Wednesday.
    • We can expect to see approximately $300 billion for the Paycheck Protection Program (with a portion of these funds set aside for small lenders), $75 billion for providers, $65 billion for the SBA Economic Injury Disaster Loan program and $25 billion for testing.
  • COVID-4: The reports of its timing keep changing, but the latest we’ve heard from Hill staff is mid-May for the package.
  • House Energy and Commerce Chairman Pallone sent a letter to the Task Force on National Testing Strategy asking inquiring what actions the Administration taking to expand testing and prepare for eventually easing its guidelines on social distancing. Chairman Pallone requested answers to these questions by April 24, 2020.
  • Senator Patty Murray released a White Paper outlining the Democrats’ proposal to increase national COVID-19 testing.

ADMINISTRATION UPDATES

  • CMS released guidelines for some health care facilities to resume non-emergent non-COVID care in areas where there is a low incidence of COVID-19.
  • CMS has updated their FAQ on Medicare Fee-for-Service (FFS) billing here.
  • CMS Administrator Seema Verma announced that CMS expects to release data on COVID-19 outcomes specific to race and ethnicity in early May once the agency has claims from April with COVID-19 codes.
  • In an effort to ramp up testing, President Trump is invoking the Defense Production Act to produce 20 million more COVID-19 testing swabs.
  • Despite announcing that COVID-19 treatment will be covered for the uninsured, the administration still has not announced a plan to operationalize this.  POLITICO reported that a portion of the Public Health Emergency Fund could be used for this purpose.

Back To Top